Header Logo

Connection

Deborah Hall to Female

Back to Details
This is a "connection" page, showing publications Deborah Hall has written about Female.
Deborah Hall
Connection Strength
1.287
Female
  1. Gender Disparities in the Career of Neurology Researchers. Neurology. 2023 01 31; 100(5):e454-e464.
    View in: PubMed
    Score: 0.066
  2. Eye Movements in Fragile X-Associated Tremor/Ataxia Syndrome. J Neuroophthalmol. 2021 12 01; 41(4):e661-e664.
    View in: PubMed
    Score: 0.062
  3. Frequency of Parkinsonism and Parkinson Disease in African Americans in the Chicago Community. J Gerontol A Biol Sci Med Sci. 2021 06 14; 76(7):1340-1345.
    View in: PubMed
    Score: 0.060
  4. Mild Neurological Signs in FMR1 Premutation Women in an Unselected Community-Based Cohort. Mov Disord. 2021 10; 36(10):2378-2386.
    View in: PubMed
    Score: 0.060
  5. The Effects of Dual Task Cognitive Interference and Fast-Paced Walking on Gait, Turns, and Falls in Men and Women with FXTAS. Cerebellum. 2021 Apr; 20(2):212-221.
    View in: PubMed
    Score: 0.058
  6. Fragile X Gray Zone Alleles Are Associated With Signs of Parkinsonism and Earlier Death. Mov Disord. 2020 08; 35(8):1448-1456.
    View in: PubMed
    Score: 0.056
  7. Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS). PLoS One. 2020; 15(2):e0225191.
    View in: PubMed
    Score: 0.055
  8. Cognitive function impacts gait, functional mobility and falls in fragile X-associated tremor/ataxia syndrome. Gait Posture. 2018 10; 66:288-293.
    View in: PubMed
    Score: 0.050
  9. The state of clinical research in neurology. Neurology. 2018 04 10; 90(15):e1347-e1354.
    View in: PubMed
    Score: 0.048
  10. A methylation PCR method determines FMR1 activation ratios and differentiates premutation allele mosaicism in carrier siblings. Clin Epigenetics. 2016; 8:130.
    View in: PubMed
    Score: 0.044
  11. Global cognitive function and processing speed are associated with gait and balance dysfunction in Parkinson's disease. J Neuroeng Rehabil. 2016 10 28; 13(1):94.
    View in: PubMed
    Score: 0.044
  12. Clinical Phenotype of Adult Fragile X Gray Zone Allele Carriers: a Case Series. Cerebellum. 2016 10; 15(5):623-31.
    View in: PubMed
    Score: 0.044
  13. Characterization and Early Detection of Balance Deficits in Fragile X Premutation Carriers With and Without Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS). Cerebellum. 2015 Dec; 14(6):650-62.
    View in: PubMed
    Score: 0.041
  14. Clinical neurogenetics: fragile x-associated tremor/ataxia syndrome. Neurol Clin. 2013 Nov; 31(4):1073-84.
    View in: PubMed
    Score: 0.035
  15. Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers. Mov Disord. 2012 Feb; 27(2):296-300.
    View in: PubMed
    Score: 0.031
  16. FMR1 gray-zone alleles: association with Parkinson's disease in women? Mov Disord. 2011 Aug 15; 26(10):1900-6.
    View in: PubMed
    Score: 0.030
  17. Pragmatic communication is impaired in Parkinson disease. Int J Neurosci. 2011 May; 121(5):254-6.
    View in: PubMed
    Score: 0.030
  18. FMR1 gene expansion and scans without evidence of dopaminergic deficits in parkinsonism patients. Parkinsonism Relat Disord. 2010 Nov; 16(9):608-11.
    View in: PubMed
    Score: 0.029
  19. Shoulder pain in Parkinson's disease: a case-control study. Mov Disord. 2010 Jun 15; 25(8):1105-6.
    View in: PubMed
    Score: 0.028
  20. Movement disorders associated with aripiprazole use: a case series. Int J Neurosci. 2009; 119(12):2274-9.
    View in: PubMed
    Score: 0.026
  21. Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease. Parkinsonism Relat Disord. 2009 Feb; 15(2):156-9.
    View in: PubMed
    Score: 0.025
  22. Paroxysmal nonkinesigenic dystonia and celiac disease. Mov Disord. 2007 Apr 15; 22(5):708-10.
    View in: PubMed
    Score: 0.023
  23. Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome. Mov Disord. 2006 Oct; 21(10):1741-4.
    View in: PubMed
    Score: 0.022
  24. Maternal risk factors for term neonatal seizures: population-based study in Colorado, 1989-2003. J Child Neurol. 2006 Sep; 21(9):795-8.
    View in: PubMed
    Score: 0.022
  25. Adult nonketotic hyperglycinemia (NKH) crisis presenting as severe chorea and encephalopathy. Mov Disord. 2004 Apr; 19(4):485-6.
    View in: PubMed
    Score: 0.018
  26. IN-HOME-PD: The effects of longitudinal telehealth-enhanced interdisciplinary home visits on care and quality of life for homebound individuals with Parkinson's disease. Parkinsonism Relat Disord. 2022 09; 102:68-76.
    View in: PubMed
    Score: 0.016
  27. Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers. Ann Neurol. 2022 03; 91(3):424-435.
    View in: PubMed
    Score: 0.016
  28. Identifying susceptibility genes for primary ovarian insufficiency on the high-risk genetic background of a fragile X premutation. Fertil Steril. 2021 09; 116(3):843-854.
    View in: PubMed
    Score: 0.015
  29. Association of Longitudinal Glycemia with Diffusion Weighted Imaging Lesions in Spontaneous Intracerebral Hemorrhage. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105554.
    View in: PubMed
    Score: 0.015
  30. KICK OUT PD: Feasibility and quality of life in the pilot karate intervention to change kinematic outcomes in Parkinson's Disease. PLoS One. 2020; 15(9):e0237777.
    View in: PubMed
    Score: 0.014
  31. Understanding the relationship between freezing of gait and other progressive supranuclear palsy features. Parkinsonism Relat Disord. 2020 09; 78:56-60.
    View in: PubMed
    Score: 0.014
  32. Hypertension and progressive supranuclear palsy. Parkinsonism Relat Disord. 2019 09; 66:166-170.
    View in: PubMed
    Score: 0.013
  33. The Influence of Weather on the Incidence of Primary Spontaneous Intracerebral Hemorrhage. J Stroke Cerebrovasc Dis. 2019 Feb; 28(2):405-411.
    View in: PubMed
    Score: 0.013
  34. Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study. Mov Disord. 2018 03; 33(3):468-472.
    View in: PubMed
    Score: 0.012
  35. Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial. JAMA Neurol. 2018 02 01; 75(2):219-226.
    View in: PubMed
    Score: 0.012
  36. Anti-inflammatory drug use and progressive supranuclear palsy. Parkinsonism Relat Disord. 2018 03; 48:89-92.
    View in: PubMed
    Score: 0.012
  37. Factors Associated With Ambulatory Activity in De Novo Parkinson Disease. J Neurol Phys Ther. 2017 Apr; 41(2):93-100.
    View in: PubMed
    Score: 0.011
  38. Understanding falls in progressive supranuclear palsy. Parkinsonism Relat Disord. 2017 02; 35:75-81.
    View in: PubMed
    Score: 0.011
  39. Gait and Functional Mobility Deficits in Fragile X-Associated Tremor/Ataxia Syndrome. Cerebellum. 2016 08; 15(4):475-82.
    View in: PubMed
    Score: 0.011
  40. Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders. Clin Neuropsychol. 2016 Aug; 30(6):849-900.
    View in: PubMed
    Score: 0.011
  41. Relationship between uric acid levels and progressive supranuclear palsy. Mov Disord. 2016 05; 31(5):663-7.
    View in: PubMed
    Score: 0.010
  42. Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study. Mov Disord. 2016 05; 31(5):644-52.
    View in: PubMed
    Score: 0.010
  43. Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited. Parkinsonism Relat Disord. 2014 Apr; 20(4):456-9.
    View in: PubMed
    Score: 0.009
  44. Exercise for people in early- or mid-stage Parkinson disease: a 16-month randomized controlled trial. Phys Ther. 2012 Nov; 92(11):1395-410.
    View in: PubMed
    Score: 0.008
  45. Profile of functional limitations and task performance among people with early- and middle-stage Parkinson disease. Phys Ther. 2011 Sep; 91(9):1339-54.
    View in: PubMed
    Score: 0.008
  46. Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine. J Clin Psychopharmacol. 2010 Oct; 30(5):642-4.
    View in: PubMed
    Score: 0.007
  47. Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. Mov Disord. 2007 Oct 31; 22(14):2018-30, quiz 2140.
    View in: PubMed
    Score: 0.006
  48. Endurance exercise training to improve economy of movement of people with Parkinson disease: three case reports. Phys Ther. 2008 Jan; 88(1):63-76.
    View in: PubMed
    Score: 0.006
  49. Neuropathic features in fragile X premutation carriers. Am J Med Genet A. 2007 Jan 01; 143A(1):19-26.
    View in: PubMed
    Score: 0.006
  50. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 05; 139B(1):115-21.
    View in: PubMed
    Score: 0.005
  51. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA. 2004 Jan 28; 291(4):460-9.
    View in: PubMed
    Score: 0.005
  52. Sonographic findings in patients with adenomyosis: can sonography assist in predicting extent of disease? AJR Am J Roentgenol. 2002 Aug; 179(2):379-83.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.